1806. FDA Limits Use of J&J Vaccine Over Blood Clotting Disorder, But Experts Say Pfizer, Moderna Shots Pose Similar Risk

The U.S. Food and Drug Administration on Thursday put strict limits on the use of Johnson & Johnson’s COVID-19 vaccine, citing the risk of a blood clotting condition, but experts say that Pfizer and Moderna pose similar risks.

READ HERE